| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
|
J Clin Oncol
|
2007
|
4.37
|
|
2
|
Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
|
Int J Urol
|
2012
|
3.17
|
|
3
|
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.
|
Eur Urol
|
2009
|
3.14
|
|
4
|
Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
|
Eur Urol
|
2011
|
3.07
|
|
5
|
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
|
Int J Radiat Oncol Biol Phys
|
2010
|
3.06
|
|
6
|
Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample.
|
Eur Urol
|
2011
|
3.03
|
|
7
|
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.
|
Eur Urol
|
2010
|
2.13
|
|
8
|
Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
|
Int J Urol
|
2012
|
2.08
|
|
9
|
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.
|
J Urol
|
2010
|
2.05
|
|
10
|
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
|
BJU Int
|
2012
|
2.03
|
|
11
|
Blood transfusions in radical prostatectomy: a contemporary population-based analysis.
|
Urology
|
2012
|
2.03
|
|
12
|
Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi.
|
Eur Urol
|
2007
|
1.96
|
|
13
|
Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma.
|
Eur Urol
|
2007
|
1.90
|
|
14
|
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.
|
J Urol
|
2010
|
1.83
|
|
15
|
A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma.
|
Eur Urol
|
2008
|
1.77
|
|
16
|
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
|
J Urol
|
2009
|
1.73
|
|
17
|
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
|
BJU Int
|
2007
|
1.68
|
|
18
|
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
|
Urology
|
2009
|
1.68
|
|
19
|
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
|
Eur Urol
|
2009
|
1.61
|
|
20
|
External validation of the updated partin tables in a cohort of French and Italian men.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.58
|
|
21
|
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
|
Urology
|
2009
|
1.58
|
|
22
|
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
|
Urology
|
2009
|
1.58
|
|
23
|
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
|
Eur Urol
|
2011
|
1.57
|
|
24
|
Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
|
Urology
|
2008
|
1.55
|
|
25
|
Thirty-day mortality after nephrectomy: clinical implications for informed consent.
|
Eur Urol
|
2008
|
1.53
|
|
26
|
Radical versus partial nephrectomy: effect on overall and noncancer mortality.
|
Cancer
|
2009
|
1.51
|
|
27
|
How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications.
|
BJU Int
|
2010
|
1.48
|
|
28
|
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
|
Eur Urol
|
2008
|
1.45
|
|
29
|
Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status.
|
Urology
|
2011
|
1.44
|
|
30
|
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.
|
Ann Surg Oncol
|
2010
|
1.43
|
|
31
|
p53 predictive value for pT1-2 N0 disease at radical cystectomy.
|
J Urol
|
2009
|
1.43
|
|
32
|
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
|
Cancer
|
2007
|
1.43
|
|
33
|
Prediction of pathological stage is inaccurate in men with PSA values above 20 ng/mL.
|
Eur Urol
|
2006
|
1.42
|
|
34
|
Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
|
Urology
|
2009
|
1.42
|
|
35
|
Leapfrog volume thresholds and perioperative complications after radical prostatectomy.
|
Cancer
|
2012
|
1.40
|
|
36
|
Laparoscopic partial nephrectomy: predictors of prolonged warm ischemia.
|
J Urol
|
2009
|
1.40
|
|
37
|
Pathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomy.
|
BJU Int
|
2010
|
1.37
|
|
38
|
A population based assessment of perioperative mortality after cystectomy for bladder cancer.
|
J Urol
|
2009
|
1.35
|
|
39
|
Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study.
|
Eur Urol
|
2009
|
1.33
|
|
40
|
The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation.
|
Eur J Cancer
|
2010
|
1.30
|
|
41
|
Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series.
|
Urology
|
2008
|
1.27
|
|
42
|
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
|
Urology
|
2008
|
1.26
|
|
43
|
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
|
Eur Urol
|
2009
|
1.21
|
|
44
|
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
|
BJU Int
|
2008
|
1.20
|
|
45
|
Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy.
|
Eur J Cancer
|
2007
|
1.19
|
|
46
|
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
|
BJU Int
|
2008
|
1.18
|
|
47
|
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.
|
Cancer Epidemiol
|
2013
|
1.16
|
|
48
|
Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.
|
J Urol
|
2010
|
1.15
|
|
49
|
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.
|
Int J Cancer
|
2008
|
1.12
|
|
50
|
Treatment management of small renal masses in the 21st century: a paradigm shift.
|
Ann Surg Oncol
|
2012
|
1.07
|
|
51
|
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
|
J Urol
|
2009
|
1.06
|
|
52
|
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy.
|
Can Urol Assoc J
|
2008
|
1.03
|
|
53
|
Conditional survival predictions after nephrectomy for renal cell carcinoma.
|
J Urol
|
2009
|
1.02
|
|
54
|
Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.
|
Prostate
|
2009
|
1.02
|
|
55
|
Prospective randomized trial of barbed polyglyconate suture to facilitate vesico-urethral anastomosis during robot-assisted radical prostatectomy: time reduction and cost benefit.
|
BJU Int
|
2012
|
1.00
|
|
56
|
A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer.
|
Cancer
|
2010
|
1.00
|
|
57
|
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.
|
J Urol
|
2011
|
1.00
|
|
58
|
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
|
Eur J Cancer
|
2009
|
0.99
|
|
59
|
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
|
J Sex Med
|
2008
|
0.99
|
|
60
|
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
|
J Urol
|
2009
|
0.98
|
|
61
|
Race affects access to nephrectomy but not survival in renal cell carcinoma.
|
BJU Int
|
2008
|
0.98
|
|
62
|
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
|
Urology
|
2009
|
0.98
|
|
63
|
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.
|
Clin Cancer Res
|
2009
|
0.97
|
|
64
|
The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted.
|
Int J Urol
|
2009
|
0.97
|
|
65
|
Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
|
Eur Urol
|
2012
|
0.96
|
|
66
|
External validation of the updated Partin tables in a cohort of North American men.
|
J Urol
|
2008
|
0.95
|
|
67
|
p53 expression in patients with advanced urothelial cancer of the urinary bladder.
|
BJU Int
|
2009
|
0.94
|
|
68
|
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
|
Eur J Cancer
|
2007
|
0.94
|
|
69
|
Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best.
|
Eur Urol
|
2008
|
0.94
|
|
70
|
Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.
|
J Urol
|
2010
|
0.94
|
|
71
|
A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.
|
Clin Cancer Res
|
2009
|
0.93
|
|
72
|
The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study.
|
Cancer Causes Control
|
2011
|
0.92
|
|
73
|
Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
|
BJU Int
|
2007
|
0.92
|
|
74
|
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.
|
Urology
|
2009
|
0.92
|
|
75
|
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
|
Urology
|
2010
|
0.90
|
|
76
|
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
|
J Urol
|
2012
|
0.89
|
|
77
|
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
|
Cancer
|
2009
|
0.88
|
|
78
|
A nomogram predicting metastatic progression after radical prostatectomy.
|
Int J Urol
|
2008
|
0.88
|
|
79
|
Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.88
|
|
80
|
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States.
|
Cancer
|
2011
|
0.87
|
|
81
|
The effect of insurance status on outcomes after partial nephrectomy.
|
Int Urol Nephrol
|
2011
|
0.87
|
|
82
|
Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
|
BJU Int
|
2011
|
0.87
|
|
83
|
Impact of caseload on total hospital charges: a direct comparison between minimally invasive and open radical prostatectomy--a population based study.
|
J Urol
|
2011
|
0.87
|
|
84
|
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
|
BJU Int
|
2010
|
0.86
|
|
85
|
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.
|
Eur J Cancer
|
2011
|
0.86
|
|
86
|
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
|
BJU Int
|
2007
|
0.86
|
|
87
|
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
|
BJU Int
|
2010
|
0.86
|
|
88
|
Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.86
|
|
89
|
Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study.
|
Ann Surg Oncol
|
2011
|
0.85
|
|
90
|
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma.
|
BJU Int
|
2009
|
0.85
|
|
91
|
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.
|
Can Urol Assoc J
|
2012
|
0.84
|
|
92
|
Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.
|
J Urol
|
2008
|
0.84
|
|
93
|
The effect of gender on nephrectomy perioperative outcomes: a national survey.
|
Can J Urol
|
2012
|
0.83
|
|
94
|
Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
|
BJU Int
|
2008
|
0.83
|
|
95
|
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
|
J Urol
|
2012
|
0.82
|
|
96
|
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
|
Eur Urol
|
2006
|
0.82
|
|
97
|
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
|
J Sex Med
|
2008
|
0.82
|
|
98
|
Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.
|
Ann Surg Oncol
|
2012
|
0.82
|
|
99
|
Is robotic surgery cost-effective: yes.
|
Curr Opin Urol
|
2012
|
0.82
|
|
100
|
A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
|
BJU Int
|
2009
|
0.81
|
|
101
|
Risk factors for biochemical recurrence following radical perineal prostatectomy in a large contemporary series: a detailed assessment of margin extent and location.
|
Urol Oncol
|
2012
|
0.81
|
|
102
|
Pazopanib trial data cannot support first-line use.
|
Nat Rev Urol
|
2010
|
0.81
|
|
103
|
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram.
|
BJU Int
|
2007
|
0.81
|
|
104
|
Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
|
Eur Urol
|
2010
|
0.81
|
|
105
|
Training and outcome monitoring in robotic urologic surgery.
|
Nat Rev Urol
|
2011
|
0.80
|
|
106
|
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
|
BJU Int
|
2009
|
0.80
|
|
107
|
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
|
BJU Int
|
2011
|
0.79
|
|
108
|
Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy.
|
J Urol
|
2011
|
0.79
|
|
109
|
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
|
Int J Urol
|
2008
|
0.79
|
|
110
|
Does partial nephrectomy at an academic institution result in better outcomes?
|
World J Urol
|
2011
|
0.79
|
|
111
|
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
|
BJU Int
|
2009
|
0.78
|
|
112
|
Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.78
|
|
113
|
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.
|
Urology
|
2009
|
0.78
|
|
114
|
Management of upper urinary tract urothelial carcinoma.
|
Expert Rev Anticancer Ther
|
2010
|
0.78
|
|
115
|
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
|
BJU Int
|
2007
|
0.78
|
|
116
|
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
|
Urology
|
2009
|
0.78
|
|
117
|
Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
|
J Sex Med
|
2007
|
0.78
|
|
118
|
The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
|
J Sex Med
|
2008
|
0.78
|
|
119
|
Can nomograms be superior to other prediction tools?
|
BJU Int
|
2008
|
0.78
|
|
120
|
Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.78
|
|
121
|
The presence of prostate cancer on saturation biopsy can be accurately predicted.
|
BJU Int
|
2009
|
0.77
|
|
122
|
Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
|
BJU Int
|
2008
|
0.77
|
|
123
|
Discharge patterns after radical prostatectomy in the United States of America.
|
Urol Oncol
|
2011
|
0.76
|
|
124
|
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
|
BJU Int
|
2008
|
0.76
|
|
125
|
Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
|
Urology
|
2010
|
0.76
|
|
126
|
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
|
Urology
|
2008
|
0.76
|
|
127
|
Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
|
BJU Int
|
2011
|
0.75
|
|
128
|
Dose escalation of second-line sunitinib results in rapid partial remission of multiple hepatic metastases.
|
Can Urol Assoc J
|
2009
|
0.75
|
|
129
|
Clinical experience and critical evaluation of the role of everolimus in advanced renal cell carcinoma.
|
Open Access J Urol
|
2011
|
0.75
|
|
130
|
The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.
|
J Urol
|
2011
|
0.75
|
|
131
|
Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study.
|
Ann Surg Oncol
|
2011
|
0.75
|
|
132
|
Open cystolithotomy for very large calculi in a Studer ileal neobladder.
|
Can J Urol
|
2015
|
0.75
|
|
133
|
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.
|
J Urol
|
2011
|
0.75
|
|
134
|
Discharge patterns after radical cystectomy: contemporary trends in the United States.
|
J Urol
|
2012
|
0.75
|
|
135
|
Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
|
BJU Int
|
2009
|
0.75
|
|
136
|
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.
|
J Endourol
|
2009
|
0.75
|
|
137
|
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.
|
Int Urol Nephrol
|
2011
|
0.75
|
|
138
|
Suspected clinical T3 prostate cancer is associated with a high rate of negative extended biopsies: clinical implications.
|
Eur Urol
|
2008
|
0.75
|